These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 11800507

  • 1. Continuous versus non-nightly use of zolpidem in chronic insomnia: results of a large-scale, double-blind, randomized, outpatient study.
    Hajak G, Cluydts R, Declerck A, Estivill SE, Middleton A, Sonka K, Unden M.
    Int Clin Psychopharmacol; 2002 Jan; 17(1):9-17. PubMed ID: 11800507
    [Abstract] [Full Text] [Related]

  • 2. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study.
    Krystal AD, Erman M, Zammit GK, Soubrane C, Roth T, ZOLONG Study Group.
    Sleep; 2008 Jan; 31(1):79-90. PubMed ID: 18220081
    [Abstract] [Full Text] [Related]

  • 3. Twelve months of nightly zolpidem does not lead to dose escalation: a prospective placebo-controlled study.
    Roehrs TA, Randall S, Harris E, Maan R, Roth T.
    Sleep; 2011 Feb 01; 34(2):207-12. PubMed ID: 21286241
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T, Soubrane C, Titeux L, Walsh JK, Zoladult Study Group.
    Sleep Med; 2006 Aug 01; 7(5):397-406. PubMed ID: 16815744
    [Abstract] [Full Text] [Related]

  • 5. Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study.
    Roehrs TA, Randall S, Harris E, Maan R, Roth T.
    J Psychopharmacol; 2012 Aug 01; 26(8):1088-95. PubMed ID: 22004689
    [Abstract] [Full Text] [Related]

  • 6. Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study.
    Roth T, Krystal A, Steinberg FJ, Singh NN, Moline M.
    Sleep; 2013 Feb 01; 36(2):189-96. PubMed ID: 23372266
    [Abstract] [Full Text] [Related]

  • 7. Comparison of continuous versus intermittent administration of zolpidem in chronic insomniacs: a double-blind, randomized pilot study.
    Cluydts R, Peeters K, de Bouyalsky I, Lavoisy J.
    J Int Med Res; 1998 Feb 01; 26(1):13-24. PubMed ID: 9513073
    [Abstract] [Full Text] [Related]

  • 8. Eight weeks of non-nightly use of zolpidem for primary insomnia.
    Walsh JK, Roth T, Randazzo A, Erman M, Jamieson A, Scharf M, Schweitzer PK, Ware JC.
    Sleep; 2000 Dec 15; 23(8):1087-96. PubMed ID: 11145323
    [Abstract] [Full Text] [Related]

  • 9. Gender Differences in the Efficacy and Safety of Chronic Nightly Zolpidem.
    Roehrs TA, Roth T.
    J Clin Sleep Med; 2016 Mar 15; 12(3):319-25. PubMed ID: 26446253
    [Abstract] [Full Text] [Related]

  • 10. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
    Fava M, Asnis GM, Shrivastava RK, Lydiard B, Bastani B, Sheehan DV, Roth T.
    J Clin Psychiatry; 2011 Jul 15; 72(7):914-28. PubMed ID: 21208597
    [Abstract] [Full Text] [Related]

  • 11. Zolpidem in the treatment of short-term insomnia: a randomized, double-blind, placebo-controlled clinical trial.
    Dockhorn RJ, Dockhorn DW.
    Clin Neuropharmacol; 1996 Aug 15; 19(4):333-40. PubMed ID: 8828996
    [Abstract] [Full Text] [Related]

  • 12. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
    Dorsey CM, Lee KA, Scharf MB.
    Clin Ther; 2004 Oct 15; 26(10):1578-86. PubMed ID: 15598474
    [Abstract] [Full Text] [Related]

  • 13. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB, Roth T, Vogel GW, Walsh JK.
    J Clin Psychiatry; 1994 May 15; 55(5):192-9. PubMed ID: 8071269
    [Abstract] [Full Text] [Related]

  • 14. A double-blind comparative study of zolpidem versus zopiclone in the treatment of chronic primary insomnia.
    Tsutsui S, Zolipidem Study Group.
    J Int Med Res; 2001 May 15; 29(3):163-77. PubMed ID: 11471853
    [Abstract] [Full Text] [Related]

  • 15. Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia.
    Perlis ML, McCall WV, Krystal AD, Walsh JK.
    J Clin Psychiatry; 2004 Aug 15; 65(8):1128-37. PubMed ID: 15323600
    [Abstract] [Full Text] [Related]

  • 16. Low-dose sublingual zolpidem tartrate is associated with dose-related improvement in sleep onset and duration in insomnia characterized by middle-of-the-night (MOTN) awakenings.
    Roth T, Hull SG, Lankford DA, Rosenberg R, Scharf MB, Intermezzo Study Group.
    Sleep; 2008 Sep 15; 31(9):1277-84. PubMed ID: 18788653
    [Abstract] [Full Text] [Related]

  • 17. Zolpidem for persistent insomnia in SSRI-treated depressed patients.
    Asnis GM, Chakraburtty A, DuBoff EA, Krystal A, Londborg PD, Rosenberg R, Roth-Schechter B, Scharf MB, Walsh JK.
    J Clin Psychiatry; 1999 Oct 15; 60(10):668-76. PubMed ID: 10549683
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial.
    Maroo N, Hazra A, Das T.
    Indian J Pharmacol; 2013 Oct 15; 45(1):34-9. PubMed ID: 23543804
    [Abstract] [Full Text] [Related]

  • 19. "As needed" pharmacotherapy combined with stimulus control treatment in chronic insomnia--assessment of a novel intervention strategy in a primary care setting.
    Hajak G, Bandelow B, Zulley J, Pittrow D.
    Ann Clin Psychiatry; 2002 Mar 15; 14(1):1-7. PubMed ID: 12046635
    [Abstract] [Full Text] [Related]

  • 20. Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients.
    Monti JM, Attali P, Monti D, Zipfel A, de la Giclais B, Morselli PL.
    Pharmacopsychiatry; 1994 Jul 15; 27(4):166-75. PubMed ID: 7972349
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.